Table 4

Relative risk of incidence and mortality related to solar UV-B exposure, northern versus southern United States boundary, non-Hispanic whites (95% CI in parentheses): Cancer sites with no evidence of an inverse association with solar UV-B exposure (see notes for Table 2).

Incidence

Mortality


Cancer site

Males

Females

Males

Females


Liver and intrahepatic bile duct

1.01 (0.95–1.08)

1.05 (0.96–1.14)

0.88 (0.85–0.92)

0.85 (0.81–0.89)

Nose, nasal cavity, and inner ear

0.80 (0.68–0.95)

0.85 (0.71–1.03)

0.93 (0.76–1.13)

0.99 (0.80–1.23)

Larynx

0.87 (0.82–0.92)

0.80 (0.72–0.89)

1.04 (0.98–1.11)

0.96 (0.86–1.07)

Bone and joint

0.83 (0.69–1.01)

0.95 (0.78–1.17)

0.62 (0.54–0.72)

0.57 (0.49–0.66)

Soft tissue, including heart

0.84 (0.77–0.92)

0.94 (0.85–1.03)

1.10 (1.02–1.19)

1.23 (1.14–1.33)

Ovary

1.03 (0.99–1.06)

1.09 (1.06–1.11)

Brain and other nervous system

1.08 (1.02–1.14)

1.07 (1.01–1.14)

0.91 (0.87–0.94)

0.86 (0.83–0.90)

Thyroid (males)

1.05 (0.96–1.13)

1.00 (0.87–1.16)

Miscellaneous sites

0.83 (0.79–0.86)

0.93 (0.89–-0.97)

1.16 (1.13–1.18)

1.23 (1.20–1.26)


Boscoe and Schymura BMC Cancer 2006 6:264   doi:10.1186/1471-2407-6-264

Open Data